The global Spinal Cord Stimulator Market is estimated to be valued at USD 3,011.0 million in 2025 and is projected to reach USD 5,291.4 million by 2035, registering a compound annual growth rate (CAGR ...

Saluda Medical announced that it appointed Barry Regan as its new president and CEO, effective July 14, 2025. Regan most ...

Innovation in obesity treatments, Alzheimer's detection and medical-device applications is setting the stage for a number of ...

According to a new comprehensive report from The Insight Partners, the electrotherapy systems market is witnessing ...

Avivomed, Inc., a privately held, clinical-stage, medical device company, announced the appointment of Dan Brounstein as its new Chief Executive Officer and Board Member. Brounstein succeeds CEO Steve ...

Boston Scientific's Neuromodulation unit witnesses 6.8% growth in the first quarter, fueled by strong gains in pain and brain ...

02.06.2021: Clinical review - Spinal cord stimulation with weak electric current is a neuromodulatory treatment suitable for subgroups of patients with chronic neuropathic pain and certain other pain ...

Spinal cord stimulation. In spinal cord stimulation, an electrode placed in the epidural space is connected to a pulse generator. In 2021, doctors and researchers at our department published a ...

LONDON, GREATER LONDON, UNITED KINGDOM, June 20, 2025 /EINPresswire.com/ -- Prominently, the neuroplasticity market size has seen significant exponential growth in recent years. In particular, the ...

Boston Scientific’s Neuromodulation segment is charging ahead with a caffeinated jolt of momentum, posting 6.8% operational ...